194 related articles for article (PubMed ID: 33624707)
1. Fatty Pancreas: Disease or Finding?
Silva LLSE; Fernandes MSS; Lima EA; Stefano JT; Oliveira CP; Jukemura J
Clinics (Sao Paulo); 2021; 76():e2439. PubMed ID: 33624707
[TBL] [Abstract][Full Text] [Related]
2. Impact of non-alcoholic fatty pancreas disease on glucose metabolism.
Yu TY; Wang CY
J Diabetes Investig; 2017 Nov; 8(6):735-747. PubMed ID: 28371475
[TBL] [Abstract][Full Text] [Related]
3. Magnetic resonance imaging: Proton density fat fraction for assessment of pancreatic fatty infiltration during progression of T2DM bama minipigs.
Chen Y; Jiang Z; Long L; Miu Y; Zhang L; Zhong D; Tang Q
J Magn Reson Imaging; 2019 Dec; 50(6):1905-1913. PubMed ID: 31006935
[TBL] [Abstract][Full Text] [Related]
4. Exploring the metabolic syndrome: Nonalcoholic fatty pancreas disease.
Catanzaro R; Cuffari B; Italia A; Marotta F
World J Gastroenterol; 2016 Sep; 22(34):7660-75. PubMed ID: 27678349
[TBL] [Abstract][Full Text] [Related]
5. Pancreatic Fat is not significantly correlated with β-cell Dysfunction in Patients with new-onset Type 2 Diabetes Mellitus using quantitative Computed Tomography.
Li YX; Sang YQ; Sun Y; Liu XK; Geng HF; Zha M; Wang B; Teng F; Sun HJ; Wang Y; Qiu QQ; Zang X; Wang Y; Wu TT; Jones PM; Liang J; Xu W
Int J Med Sci; 2020; 17(12):1673-1682. PubMed ID: 32714070
[No Abstract] [Full Text] [Related]
6. Non-alcoholic fatty pancreas disease.
Alempijevic T; Dragasevic S; Zec S; Popovic D; Milosavljevic T
Postgrad Med J; 2017 Apr; 93(1098):226-230. PubMed ID: 28069746
[TBL] [Abstract][Full Text] [Related]
7. Clinical implications of fatty pancreas: correlations between fatty pancreas and metabolic syndrome.
Lee JS; Kim SH; Jun DW; Han JH; Jang EC; Park JY; Son BK; Kim SH; Jo YJ; Park YS; Kim YS
World J Gastroenterol; 2009 Apr; 15(15):1869-75. PubMed ID: 19370785
[TBL] [Abstract][Full Text] [Related]
8. [Effects of octreotide on fatty infiltration of the pancreas in high-fat diet induced obesity rats].
Yu T; Liu R; Li M; Li X; Qiang O; Huang W; Tang C
Wei Sheng Yan Jiu; 2014 Mar; 43(2):186-92. PubMed ID: 24868966
[TBL] [Abstract][Full Text] [Related]
9. PANCREATIC STEATOSIS: A NEW DIAGNOSIS AND THERAPEUTIC CHALLENGE IN GASTROENTEROLOGY.
Paul J; Shihaz AVH
Arq Gastroenterol; 2020; 57(2):216-220. PubMed ID: 32490903
[TBL] [Abstract][Full Text] [Related]
10. Non-Alcoholic Fatty Pancreas Disease (NAFPD): A Silent Spectator or the Fifth Component of Metabolic Syndrome? A Literature Review.
Romana BS; Chela H; Dailey FE; Nassir F; Tahan V
Endocr Metab Immune Disord Drug Targets; 2018; 18(6):547-554. PubMed ID: 29595117
[TBL] [Abstract][Full Text] [Related]
11. Pancreatic steatosis and metabolic pancreatic disease: a new entity?
Caldart F; de Pretis N; Luchini C; Ciccocioppo R; Frulloni L
Intern Emerg Med; 2023 Nov; 18(8):2199-2208. PubMed ID: 37462859
[TBL] [Abstract][Full Text] [Related]
12. Nonalcoholic Fatty Pancreas Disease: Role in Metabolic Syndrome, "Prediabetes," Diabetes and Atherosclerosis.
Filippatos TD; Alexakis K; Mavrikaki V; Mikhailidis DP
Dig Dis Sci; 2022 Jan; 67(1):26-41. PubMed ID: 33469809
[TBL] [Abstract][Full Text] [Related]
13. [Lipid accumulation in the pancreas: clinical significance of NAFPD (non-alcoholic fatty pancreas disease)].
Jermendy G
Orv Hetil; 2022 Oct; 163(44):1735-1742. PubMed ID: 36309887
[TBL] [Abstract][Full Text] [Related]
14. Type 2 diabetes: Does pancreatic fat really matter?
Guglielmi V; Sbraccia P
Diabetes Metab Res Rev; 2018 Feb; 34(2):. PubMed ID: 28984071
[TBL] [Abstract][Full Text] [Related]
15. Fatty Pancreas: An Underappreciated Intersection of the Metabolic Profile and Pancreatic Adenocarcinoma.
Swislocki A
Metab Syndr Relat Disord; 2021 Aug; 19(6):317-324. PubMed ID: 33656378
[TBL] [Abstract][Full Text] [Related]
16. Pancreatic fat content is associated with β-cell function and insulin resistance in Chinese type 2 diabetes subjects.
Lu T; Wang Y; Dou T; Xue B; Tan Y; Yang J
Endocr J; 2019 Mar; 66(3):265-270. PubMed ID: 30700664
[TBL] [Abstract][Full Text] [Related]
17. Pancreatic adipose tissue infiltration, parenchymal steatosis and beta cell function in humans.
Begovatz P; Koliaki C; Weber K; Strassburger K; Nowotny B; Nowotny P; Müssig K; Bunke J; Pacini G; Szendrödi J; Roden M
Diabetologia; 2015 Jul; 58(7):1646-55. PubMed ID: 25740696
[TBL] [Abstract][Full Text] [Related]
18. Obesity, metabolic disease and the pancreas-Quantitative imaging of pancreatic fat.
Sakai NS; Taylor SA; Chouhan MD
Br J Radiol; 2018 Sep; 91(1089):20180267. PubMed ID: 29869917
[TBL] [Abstract][Full Text] [Related]
19. Fatty pancreas, insulin resistance, and β-cell function: a population study using fat-water magnetic resonance imaging.
Wong VW; Wong GL; Yeung DK; Abrigo JM; Kong AP; Chan RS; Chim AM; Shen J; Ho CS; Woo J; Chu WC; Chan HL
Am J Gastroenterol; 2014 Apr; 109(4):589-97. PubMed ID: 24492753
[TBL] [Abstract][Full Text] [Related]
20. Nonalcoholic Fatty Pancreas Disease.
Shah N; Rocha JP; Bhutiani N; Endashaw O
Nutr Clin Pract; 2019 Oct; 34 Suppl 1():S49-S56. PubMed ID: 31535735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]